Compare ENIC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENIC | GRFS |
|---|---|---|
| Founded | 2016 | 1940 |
| Country | Chile | Spain |
| Employees | N/A | 25247 |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.8B |
| IPO Year | 2015 | N/A |
| Metric | ENIC | GRFS |
|---|---|---|
| Price | $3.85 | $7.49 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $10.15 |
| AVG Volume (30 Days) | 487.1K | ★ 817.0K |
| Earning Date | 03-02-2026 | 07-28-2022 |
| Dividend Yield | ★ 4.69% | 1.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $96,491.22 | $5.33 |
| Revenue Next Year | $2.63 | $6.50 |
| P/E Ratio | $101.18 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.85 | $6.19 |
| 52 Week High | $4.51 | $11.14 |
| Indicator | ENIC | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 40.47 | 30.68 |
| Support Level | $3.85 | N/A |
| Resistance Level | $3.96 | $9.11 |
| Average True Range (ATR) | 0.11 | 0.19 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 13.31 | 10.80 |
Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.